Medical specialists from France tagged as investigators in clinical trials studying Sjogren's Syndrome

Total 44 results

Alban DEROUX, MD
Seen in:
- Grenoble, Chu Grenoble Alpes
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Alexis BOCQUET, MD
Seen in:
- Grenoble, Chu Grenoble Alpes
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Amélie SERVATTAZ, MD PhD
Seen in:
- Reims, CHU Reims
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Anne-Emmanuelle DEPINCE-BERGER, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Arnaud HOT, MD PhD
Seen in:
- Lyon, Hopital Edouard Herriot - CHU Lyon
Trials:
- NCT03003572 (Principal Investigator)
Conditions:
- Primary Sjögren's Syndrome
Aurélie MADELON, MD
Seen in:
- Grenoble, Chu Grenoble Alpes
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Béatrice PALLOT-PRADES, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
- Saint-Étienne, CHU Saint Etienne
Trials:
- NCT03003572 (Sub-Investigator)
- NCT04470453 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome;
- Rheumatoid Arthritis
Catherine Dunyach Remy
Seen in:
- Nîmes, CHU de Nîmes
Trials:
- NCT04462601 (Sub-Investigator)
Conditions:
- Sjogren's Syndrome
Cécile-Audrey DUREL, MD
Seen in:
- Lyon, Hopital Edouard Herriot - CHU Lyon
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Christophe RICHEZ, Prof
Seen in:
- Bordeaux, CHU de Bordeaux - Médecine Interne et Immunologie Clinique
- Bordeaux, CHU de Bordeaux - Service d'Immunologie et Immunogénétique
- Bordeaux, CHU de Bordeaux - service de médecine interne
- Bordeaux, CHU de Bordeaux - service de rhumatologie
Trials:
- NCT03698071 (Sub-Investigator)
- NCT03841318 (Sub-Investigator)
- NCT05698173 (Sub-Investigator)
- NCT04276701 (Sub-Investigator)
- NCT04196868 (Principal Investigator)
- NCT04870203 (Principal Investigator)
- NCT05961267 (Principal Investigator)
Conditions:
Claire BERNARD, MD
Seen in:
- Lyon, Hôpital de la Croix Rousse
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Erik Arnaud
Seen in:
- Nîmes, CHU de Nîmes
Trials:
- NCT04462601 (Sub-Investigator)
Conditions:
- Sjogren's Syndrome
Estibaliz LAZARO, Prof
Seen in:
- Bordeaux, CHU de Bordeaux - Médecine Interne et Immunologie Clinique
- Bordeaux, CHU de Bordeaux - Service d'Immunologie et Immunogénétique
- Bordeaux, CHU de Bordeaux - service de médecine interne
- Bordeaux, CHU de Bordeaux - service de rhumatologie
- Pessac, CHU de Bordeaux - service de médecine interne
Trials:
- NCT03698071 (Sub-Investigator)
- NCT05098704 (Sub-Investigator)
- NCT03841318 (Sub-Investigator)
- NCT05698173 (Sub-Investigator)
- NCT04276701 (Sub-Investigator)
- NCT04005638 (Sub-Investigator)
- NCT04265144 (Sub-Investigator)
- NCT05961267 (Sub-Investigator)
Conditions:
Françoise SARROT-REYNAULD, MD
Seen in:
- Grenoble, Chu Grenoble Alpes
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Héloïse MUNOZ-PONS, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Hubert MAROTTE, MD PhD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
- Saint-Étienne, CHU SAINT-ETIENNE
Trials:
- NCT05571514 (Sub-Investigator)
- NCT03003572 (Sub-Investigator)
Conditions:
- Post Menopausal Osteoporosis;
- Primary Sjögren's Syndrome
Isabelle DURIEU, MD
Seen in:
- Lyon, CH Lyon sud
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Isabelle GUICHARD, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome
Jean-Baptiste GAULTIER, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
- Saint Etienne, CHU de Saint Etienne
- Saint-Etienne, CHU de Saint-Etienne
Trials:
- NCT02579954 (Sub-Investigator)
- NCT03003572 (Sub-Investigator)
- NCT02800941 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension;
- Primary Sjögren's Syndrome
Jean-Christophe LEGA, MD
Seen in:
- Lyon, CH Lyon sud
Trials:
- NCT03003572 (Principal Investigator)
Conditions:
- Primary Sjögren's Syndrome
Jean-Philippe Lavigne
Seen in:
- Gard, Nîmes, Nîmes University Hospital
- Nîmes, CHU de Nîmes
Trials:
- NCT04584320 (Sub-Investigator)
- NCT04462601 (Sub-Investigator)
- NCT04820985 (Sub-Investigator)
- NCT05319067 (Sub-Investigator)
- NCT06292598 (Sub-Investigator)
Conditions:
Jonathan Broner
Seen in:
- Nîmes, CHU de Nîmes
Trials:
- NCT04462601 (Sub-Investigator)
Conditions:
- Sjogren's Syndrome
Karima BOUSSOUALIM, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
- Saint-Étienne, CHU Saint Etienne
- Saint-Étienne, CHU de Saint-Etienne
Trials:
- NCT03003572 (Sub-Investigator)
- NCT04470453 (Sub-Investigator)
- NCT05259553 (Sub-Investigator)
Conditions:
Laurence BOUILLET, MD PhD
Seen in:
- Grenoble, Chu Grenoble Alpes
Trials:
- NCT03003572 (Principal Investigator)
Conditions:
- Primary Sjögren's Syndrome
Marc RUIVARD, MD PhD
Seen in:
- Clermont-Ferrand, CHU Estaing - Clermont Ferrand
Trials:
- NCT03003572 (Principal Investigator)
Conditions:
- Primary Sjögren's Syndrome
Marielle ROUX, MD
Seen in:
- Bourgoin-Jallieu, CH Pierre Oudot
Trials:
- NCT03003572 (Principal Investigator)
Conditions:
- Primary Sjögren's Syndrome
Marion Couderc
Seen in:
- Clermont-Ferrand, CHU de Clermont-Ferrand
Trials:
- NCT05782049 (Principal Investigator)
Conditions:
Martin KILLIAN, MD
Seen in:
- Saint Etienne, CHU SAINT-ETIENNE
- Saint-Etienne, CHU de Saint-Etienne
Trials:
- NCT03003572 (Sub-Investigator)
- NCT05857241 (Sub-Investigator)
Conditions:
Mathieu GERFAUD-VALENTIN, MD
Seen in:
- Lyon, Hôpital de la Croix Rousse
Trials:
- NCT03003572 (Sub-Investigator)
Conditions:
- Primary Sjögren's Syndrome

Clinical Trials on Sjogren's Syndrome

The Cleveland Clinic
Bristol-Myers Squibb

Withdrawn

Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study

Rheumatoid Arthritis | Inflammatory Arthritis | Primary Sjogren's Syndrome | Secondary Sjogren's Syndrome

United States
RemeGen Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

China
Stanford University

Withdrawn

Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome

Primary Sjogren's Syndrome
Matthew C. Baker

Withdrawn

BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome (BAFF/IL-17)

Primary Sjogren's Syndrome

United States
University College, London
Cambridge University Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals... and other collaborators

Active, not recruiting

Paediatric Sjögren Syndrome Cohort Study and Repository (PaedSSCoRe) (PaedSSCoRe)

Sjogren's Syndrome Childhood-onset

United Kingdom, Ireland
Keio University

Unknown

Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome

Primary Sjogren's Syndrome

Japan
Parion Sciences

Completed

A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome

Xerostomia | Dry Mouth Associated With Sjogren's Syndrome

United States
AbbVie

Withdrawn

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Sjogren's Syndrome (SS)

Netherlands
University Hospital Muenster
Novartis

Completed

Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

Germany
Kahramanmaras Sutcu Imam University

Not yet recruiting

Investigation of the Effectiveness of Cognitive Exercise Therapy Approach in Patients With Primary Sjögren's Syndrome

Primer Sjogren's Syndrome

Turkey

Medical specialists from France tagged as investigators in clinical trials studying Sjogren's Syndrome

Clinical Trials on Sjogren's Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations